Medicine and Dentistry
Phlebothrombosis
100%
Thromboprophylaxis
50%
Dentoalveolar Surgery
50%
Rivaroxaban
50%
Direct Oral Anticoagulant
50%
Venous Thromboembolism
50%
Protein Tyrosine Kinase
50%
Prevalence
50%
Janus Kinase
50%
Myeloproliferative Disorder
50%
Mesenteric Vein Thrombosis
25%
Anticoagulation
17%
Bleeding
14%
Procoagulant
12%
Post-Thrombotic Syndrome
10%
Health Care Cost
10%
Recurrent Disease
10%
Health Care Provider
10%
Secondary Care
10%
Health Care
10%
Carer Health
10%
Odds Ratio
10%
Tooth Extraction
7%
Oral Surgery
7%
Thrombosis
7%
Treatment Planning
7%
Postoperative Hemorrhage
7%
Platelet
6%
Liver Abscess
6%
Clinical Significance
6%
Umbilical Vein
6%
Cell Count
6%
Hemoglobin Determination
6%
Sepsis
6%
Polymerase Chain Reaction
6%
Thrombophilia
6%
Somatic Mutation
6%
Allele
6%
Hematocrit
6%
Chronic Pancreatitis
6%
Leukocyte
6%
Pharmacology, Toxicology and Pharmaceutical Science
Rivaroxaban
100%
Venous Thromboembolism
60%
Pharmacokinetic
50%
Vein Thrombosis
50%
Myeloproliferative Disorder
50%
Protein Tyrosine Kinase
50%
Prevalence
50%
Janus Kinase
50%
Mesenteric Vein Thrombosis
25%
Procoagulant
12%
Postthrombosis Syndrome
10%
Recurrent Disease
10%
Creatinine
6%
Chronic Pancreatitis
6%
Sepsis
6%
Thrombophilia
6%
Liver Abscess
6%
Biochemistry, Genetics and Molecular Biology
Tyrosine Kinase
50%
Phlebothrombosis
50%
Receptor Tyrosine Kinase
50%
Janus Kinase
50%
Prevalence
50%
Thrombophilia
10%
Somatic Mutation
10%
Platelet Count
10%
Polymerase Chain Reaction
10%
Allele
10%
Hematocrit
10%
Acquired Disorder
10%
Leukocyte Count
10%
